Tetra Bio Pharma Sees Two Products Approved By Health Canada

As The Deep Dive reported on late yesterday afternoon, Tetra Bio Pharma (TSXV: TBP) has received approval from Health Canada for over the counter products. The catch, is that the company has actually received approval for two separate products from the regulator. Both products are to be marketed under the Terpacan banner.

The products, referred to as Terpacan (hemorrhoids) and Terpacan (back & muscle pain) are expected to be arriving on Canadian pharmacy shelves by mid-2020. The company is currently in the process of finalizing supply, sales, and distribution agreements with “several companies.”

Tetra Bio Pharma also anticipates on acquiring sales in international jurisdictions within 2020, which includes both the United States and Europe. Terpacan is currently waiting on final marketing approval in these regions, however they are expected to be acquired in the near term. The company currently anticipates a late year launch in the United States, where it is in the process of finalizing a manufacturing agreement.

Tetra Bio Pharma last traded at $0.56 on the TSX Venture.


Information for this briefing was found via Sedar, Health Canada and Tetra Bio-Pharma. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

2026 Could Be Gold’s Biggest Year Yet!? | Ryan King – Equinox Gold

Gold Is Screaming Higher While Currencies Burn | Simon Ridgway – Rackla Metals

We Have the Highest-Grade Antimony Deposit in North America!? | Jim Atkinson -Antimony Resources

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Drug Trade: The Three Basic Cannabis Health Company Archetypes

The popular belief that cannabis will work its way further into mainstream culture and further...

Saturday, December 21, 2019, 08:00:00 AM

Market Movers: Tetra Bio-Pharma

Cannabis adjacent pharma-co Tetra Bio-Pharma (TSXV: TBP) was the most active symbol on the TSX.V...

Tuesday, November 26, 2019, 02:45:06 PM

Tetra Bio Pharma Sees Product Approved For FDA Fast Track Designation Request

Tetra Bio-Pharma (TSXV: TBP) has received a much anticipated response from the US Food and...

Monday, February 3, 2020, 08:47:08 AM

Tetra Bio Pharma To Conduct $10 Million Bought Deal Financing

Tetra Bio Pharma (TSXV: TBP) this morning announced that it will be conducting a financing...

Tuesday, January 21, 2020, 08:52:56 AM

Tetra Bio Pharma Sees Drug Approved By Health Canada

Tetra Bio Pharma (TSXV: TBP) is currently seeing upward price momentum on the discovery that...

Thursday, January 16, 2020, 03:42:12 PM